drugset / Trial / NCT03393572
Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare between the addition of Mg sulphate or Nalbuphine to intraperitoneal bupivacaine installation in laparoscopic hysterectomy for postoperative pain control and their relative adverse effects.
Timeline
- Start
- 2018-01-03
- Primary completion
- 2018-06-05
- Completion
- 2018-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Magnesium Sulfate | Other / unclassified | 30 mg/kg | Other |
| Comparator | Nalbuphine | Small molecule | 5 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 30 ml | Other |
Indications
No indication recorded.